Noreen Henig

Insider Reports History

Location
C/O Kezar Life Sciences, Inc., 4000 Shoreline Court, Suite 300, South San Francisco, CA
Signature
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Noreen Henig:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avidity Biosciences, Inc. Director Common Stock 6.69K $196K $29.33 Jun 10, 2025 Direct
Kezar Life Sciences, Inc. Chief Medical Officer Employee Stock Option (right to buy) 220K Jul 24, 2023 Direct
Avidity Biosciences, Inc. Director Stock Option (Right to Buy) 10K Jun 10, 2025 Direct

Insider Reports Filed by Noreen Henig

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNA Avidity Biosciences, Inc. Jun 10, 2025 2 $0 4 Jun 12, 2025 Director
RNA Avidity Biosciences, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
KZR Kezar Life Sciences, Inc. Jul 24, 2023 8 $0 4 Jul 26, 2023 Chief Medical Officer
RNA Avidity Biosciences, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
KZR Kezar Life Sciences, Inc. Jan 8, 2023 1 $0 4 Jan 10, 2023 Chief Medical Officer
RNA Avidity Biosciences, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
KZR Kezar Life Sciences, Inc. Jan 5, 2022 1 $0 4 Jan 7, 2022 Chief Medical Officer
RNA Avidity Biosciences, Inc. Jun 16, 2021 1 $0 4 Jun 16, 2021 Director